Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Minerva Neurosciences, Inc (NERV)

« Back to company index

NERV Chatter Timeline

Stock Ticker for NERV

Most Active Tweeters for NERV

UserTweets
@Tickeron 7
@1MinuteStock 3
@macondailynews 2
@ZolmaxNews 2
@TheMarketsDaily 1

Recent Tweets for NERV

ZolmaxNews @ZolmaxNews
Minerva Neurosciences Inc $NERV Expected to Post Earnings of -$0.39 Per Share https://t.co/rgHduwBfB8
12:09am
dailypoliticaln @dailypoliticaln
Minerva Neurosciences Inc $NERV Expected to Post Earnings of -$0.39 Per Share https://t.co/l5iGxTWSTq
September 15th 2019, 11:09pm
ZolmaxNews @ZolmaxNews
Minerva Neurosciences Inc $NERV Expected to Post Earnings of -$0.39 Per Share https://t.co/IOZM13WjCz
September 15th 2019, 11:09pm
1MinuteStock @1MinuteStock
Btw, Estimated #Earnings Per Share for $NERV is $-0.33 it's -4.13% of the current price https://t.co/NvzH3TWwpf
September 15th 2019, 3:09pm
1MinuteStock @1MinuteStock
Unicorn Bay rating for $NERV is 1.62 out of 5. https://t.co/Yw8Ovac3CC
September 15th 2019, 2:09pm
1MinuteStock @1MinuteStock
Wondering about risks of $NERV? The 21-day volatility is 18.33% https://t.co/45O6VTP8gm
September 15th 2019, 1:09pm
dispatchtribune @dispatchtribune
Minerva Neurosciences $NERV Upgraded at ValuEngine https://t.co/TpbPQzS4gN
September 14th 2019, 6:09pm
OlympiaReport @OlympiaReport
ValuEngine Upgrades Minerva Neurosciences $NERV to “Strong-Buy” https://t.co/ruAZ4k3oQE
September 14th 2019, 6:09pm
WeekHerald @WeekHerald
Minerva Neurosciences $NERV Upgraded at ValuEngine https://t.co/CSAqcJFaq6
September 14th 2019, 6:09pm
Tickeron @Tickeron
$NERV in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on January 3, 2019. View odds for th… https://t.co/kiREhvP3yH
September 14th 2019, 5:09am
dakotafinancial @dakotafinancial
Minerva Neurosciences Inc $NERV Expected to Announce Earnings of -$0.39 Per Share https://t.co/3KZYvaNDWE
September 13th 2019, 7:09pm
macondailynews @macondailynews
Minerva Neurosciences $NERV Shares Up 12.1% https://t.co/tbVnyknjXY
September 13th 2019, 1:09pm
Tickeron @Tickeron
$NERV's price moved above its 50-day Moving Average on July 2, 2019. View odds for this and other indicators:… https://t.co/D05mleBPtA
September 13th 2019, 2:09am
TheMarketsDaily @TheMarketsDaily
Minerva Neurosciences $NERV Upgraded to Strong-Buy at ValuEngine https://t.co/JdmqHimQl3
September 13th 2019, 1:09am
macondailynews @macondailynews
ValuEngine Upgrades Minerva Neurosciences $NERV to Strong-Buy https://t.co/aarqSYksTp
September 13th 2019, 1:09am
Tickeron @Tickeron
$NERV in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/uhBmqe2uFt
September 12th 2019, 3:09am
BehaviorFin @BehaviorFin
RT @semodough: $NERV Catalysts 4Q19 Top-line, pivotal Phase 3 results for roluperidone in schizophrenia negative symptoms, Top-line Phase 2…
September 12th 2019, 2:09am
ThisLincolnian @ThisLincolnian
Minerva Neurosciences $NERV Stock Rating Upgraded by ValuEngine https://t.co/IIvEFpX869
September 12th 2019, 12:09am
bbnsnews @bbnsnews
Minerva Neurosciences $NERV Trading Up 12.1% https://t.co/MZT11fEKZb
September 11th 2019, 10:09pm
jesse_brodkin @jesse_brodkin
@fezziwig2008 @runbkswm1 Please remind me what they lied about (honest question) $nerv
September 11th 2019, 5:09pm
4thQuarterCap @4thQuarterCap
Trimmed $NERV +15% at the prior 8.50 resistance area ahead of data to minimize risk https://t.co/Le8kEaHKJc
September 11th 2019, 4:09pm
ConsumerFeed @ConsumerFeed
-$0.39 Earnings Per Share Expected for Minerva Neurosciences Inc $NERV This Quarter https://t.co/N2dz7277JM
September 11th 2019, 3:09pm
bhtrade @bhtrade
$NERV anybody else catch this breakout this morning? Volume is low, so not super excited yet; but staying long for… https://t.co/WyukiMfFsG
September 11th 2019, 1:09pm
tradersreport @tradersreport
RT @Tickeron: $NERV in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://t.co/Iz2uEsriNf #Minerv…
September 11th 2019, 3:09am
Tickeron @Tickeron
$NERV in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/tC8U7VBfoC
September 11th 2019, 3:09am
Tickeron @Tickeron
$NERV in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/k3ZLAGGgnx
September 10th 2019, 3:09am
Tickeron @Tickeron
$NERV in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/rnNJa1OU0j
September 9th 2019, 1:09am
Tickeron @Tickeron
$NERV in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/KiX23Y6GDB
September 8th 2019, 3:09am
AmericanBanking @AmericanBanking
Analysts Anticipate Minerva Neurosciences Inc $NERV Will Announce Earnings of -$0.39 Per Share https://t.co/U32R3Y0A44 #stocks
September 8th 2019, 2:09am
Tickeron @Tickeron
$NERV in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on January 3, 2019. View odds for th… https://t.co/TClYPTToyq
August 11th 2019, 2:08am
dailypoliticaln @dailypoliticaln
Minerva Neurosciences $NERV Upgraded to Strong-Buy at Zacks Investment Research https://t.co/CuHZBAvij8
August 10th 2019, 5:08pm
EnterpriseLeade @EnterpriseLeade
Minerva Neurosciences $NERV Stock Rating Upgraded by ValuEngine https://t.co/wJQZAG6gPB
August 10th 2019, 4:08am
registrarjourn @registrarjourn
Minerva Neurosciences $NERV Stock Rating Upgraded by ValuEngine https://t.co/JLAIcUNrsH
August 10th 2019, 4:08am
WeekHerald @WeekHerald
Minerva Neurosciences $NERV Stock Rating Upgraded by ValuEngine https://t.co/NYWGt2aKTH
August 10th 2019, 4:08am
TickerReport @TickerReport
Research Analysts Set Expectations for Minerva Neurosciences Inc’s Q3 2019 Earnings $NERV https://t.co/rchsQsupNA
August 10th 2019, 3:08am
Tickeron @Tickeron
$NERV in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on January 3, 2019. View odds for th… https://t.co/XPkeL3zCan
August 10th 2019, 3:08am
Tickeron @Tickeron
$NERV in Downtrend: 50-day Moving Average broke below 200-day Moving Average on January 3, 2019. View odds for this… https://t.co/3OvjzmC9ty
August 9th 2019, 1:08am
dispatchtribune @dispatchtribune
Minerva Neurosciences $NERV Stock Rating Upgraded by ValuEngine https://t.co/6ivV6PNu2y
August 8th 2019, 9:08am
OlympiaReport @OlympiaReport
Minerva Neurosciences $NERV Lifted to “Buy” at ValuEngine https://t.co/rWiJgIlfWA
August 8th 2019, 9:08am
TickerReport @TickerReport
Minerva Neurosciences $NERV Stock Rating Upgraded by ValuEngine https://t.co/X2xbnMMJcL
August 8th 2019, 9:08am
ChartMill @ChartMill
In the last month $NERV has a been trading in the 6.26 - 7.49 range, which is quite wide. https://t.co/yLKmTDZkk8 https://t.co/fMLxvf3UsS
August 8th 2019, 4:08am
Tickeron @Tickeron
$NERV in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on January 3, 2019. View odds for th… https://t.co/lhwFHOEBG2
August 8th 2019, 3:08am
dakotafinancial @dakotafinancial
Minerva Neurosciences $NERV Announces Earnings Results, Beats Estimates By $0.10 EPS https://t.co/9eJ47TQAyy
August 7th 2019, 3:08pm
WingTrades @WingTrades
thoughts on $NERV? https://t.co/fDJAKc9UaN
August 7th 2019, 2:08pm
Tickeron @Tickeron
$NERV in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on January 3, 2019. View odds for th… https://t.co/tGE5GhBnbq
August 7th 2019, 3:08am
dispatchtribune @dispatchtribune
Minerva Neurosciences $NERV Issues Earnings Results https://t.co/y2No3tQEMa
August 6th 2019, 4:08pm
registrarjourn @registrarjourn
Minerva Neurosciences $NERV Issues Quarterly Earnings Results https://t.co/jqugj0ZrGN
August 6th 2019, 4:08pm
EnterpriseLeade @EnterpriseLeade
Minerva Neurosciences $NERV Issues Quarterly Earnings Results https://t.co/SwGMoHKlZb
August 6th 2019, 4:08pm
OlympiaReport @OlympiaReport
Minerva Neurosciences $NERV Releases Earnings Results, Beats Expectations By $0.10 EPS https://t.co/JUuJhzjOE4
August 6th 2019, 4:08pm
WeekHerald @WeekHerald
Minerva Neurosciences $NERV Issues Earnings Results https://t.co/BCBsMcZOqs
August 6th 2019, 3:08pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.